https://www.selleckchem.com/pr....oducts/Camptothecine
atients with evidence of myocardial injury and left ventricular dysfunction. This study sought to assess target lesion failure (TLF) and clinically driven target lesion revascularization (CD-TLR) through 1 year following second-generation drug-eluting magnesium scaffold (Magmaris) implantation using a dedicated technique (so-called '4 P's' strategy). The 4 P's strategy stands for correct patient selection, proper scaffold sizing, pre-dilatation (20% residual stenosis), post-dilatation. All the patient and lesion characteristic
Like
Comment
Share
